Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Host cells and immune system – non-specific cellular infection via viral replication refers to the broad biological process where viruses hijack host cellular machinery to propagate, triggering a multi-faceted immune response. This process is not a single molecular target, such as a single receptor or enzyme, but rather a complex series of interactions involving both viral and host factors (NIH, 2023). The process begins with viral attachment to host cell receptors, followed by entry, genome replication using host machinery, and the eventual release of new virions (Nature Reviews Microbiology, 2020). Simultaneously, the host immune system recognizes viral components, leading to the production of interferons and the recruitment of immune cells to clear the infection (Janeway's Immunobiology, 2017). Drugs associated with this process include direct-acting antivirals like Remdesivir, which inhibits viral RNA polymerase, and immunomodulators like interferons that enhance the host's antiviral state (StatPearls, 2023). Because this description encompasses an entire disease pathway rather than a discrete protein, it is categorized as a system-level interaction rather than a specific therapeutic target. Therapeutic challenges in this area include the high mutation rates of viruses leading to drug resistance and the risk of host toxicity when targeting shared cellular pathways (Nature Reviews Drug Discovery, 2020).
Inhibition of viral replication cycles and modulation of host immune responses to viral pathogens.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host cells and immune system – non-specific cellular infection via viral replication.